BrainBlog

Reliability of repeated cognitive assessment of dementia using a brief computerized battery American Journal of Alzheimers Disease and Other Dementias. 2011 Jun; 26(4): 326-333. Hammers D, Spurgeon E, Ryan K, Persad C, Heidebrink J, Barbas N, Albin R, Frey K, Darby D, Giordani B Abstract OBJECTIVE: The aim of this study was to evaluate the short-term stability and reliability of a brief computerized cognitive battery in established dementia types. METHOD: Patients were administered the computerized battery twice with administrations approximately 2 hours apart, with intervening conventional neuropsychological tests. Patients were classified clinically, via consensus conference, as healthy controls (n = 23), mild cognitive impairment (n = 20), Alzheimer's disease (n = 52), dementia with Lewy Bodies ([DLB], n = 10), or frontotemporal dementia (n = 9). RESULTS: Minimal practice effects were evident across Cog-State test administrations. Small magnitude improvements were seen across a...

The Telegraph has a link to a series of Lumosity games: Available here

A United BioSource Corporation press release from 10th September, 2009: United BioSource Corporation (UBC) today announced the acquisition of Cognitive Drug Research, Ltd. (CDR) , the leader in computerized cognitive testing for clinical trials. The CDR System is the most widely used computerized cognitive testing system in the world: it is used in more than 1000 trials encompassing approximately 50 different disease areas, validated in over 60 languages, and cited in more than 700 publications and abstracts. Additionally, CDR maintains the industry’s largest healthy subject, patient, and drug databases of cognitive effects, providing the standard for establishing the clinical relevance of compounds. Read the full press release